Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Enbrel cost per dose?

See the DrugPatentWatch profile for Enbrel

Enbrel's cost per dose varies significantly depending on factors such as insurance coverage, dosage, and the specific formulation. Without insurance, a single dose of Enbrel can range from approximately $500 to $1,000 or more [1].

What influences Enbrel's price?


The price of Enbrel is impacted by several factors. These include the patient's insurance plan and any co-pay assistance programs they may be eligible for, as well as the prescribed dosage and the frequency of administration. The specific formulation of Enbrel, such as prefilled syringes or auto-injectors, can also influence cost [1].

How much do people actually pay for Enbrel with insurance?


With insurance, out-of-pocket costs for Enbrel are typically much lower than the list price. Co-pays can range from a small amount to several hundred dollars per dose, depending on the insurance plan's formulary and deductible. Many patients utilize manufacturer co-pay assistance programs, which can reduce their out-of-pocket expenses to as low as $0 to $20 per month, though these programs have specific eligibility requirements and annual limits [1].

When does Enbrel's patent expire?


Enbrel (etanercept) has faced patent challenges and has multiple patents associated with its formulation and use. The primary patents have expired, allowing for the development of biosimilar versions. For example, some sources indicate key patents expired around 2017-2019 [2].

What are the biosimilar alternatives to Enbrel?


Biosimilar versions of etanercept are available and are designed to be highly similar to Enbrel. These biosimilars offer a potentially lower-cost alternative for patients and healthcare systems. Examples include Erelzi, developed by Sandoz, and Eticovo, developed by Samsung Bioepis and Merck [3].

How do biosimilar costs compare to Enbrel?


Biosimilars are generally priced lower than the originator biologic, Enbrel. While specific pricing varies, biosimilars aim to provide cost savings, with discounts often ranging from 10% to 50% compared to the brand-name drug [3]. This price difference can make treatment more accessible.

What is the dosing for Enbrel?


The typical dosage for Enbrel depends on the condition being treated. For rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in adults, the standard dose is 50 mg once weekly or 50 mg twice weekly for the first 12 weeks, followed by 50 mg once weekly. For plaque psoriasis in adults, it is typically 50 mg once weekly or 50 mg twice weekly for the first 12 weeks, then 50 mg once weekly [4]. Pediatric dosing varies based on weight and condition [4].

Sources:
[1] https://www.drugpatentwatch.com/drugs/enbrel
[2] https://www.drugpatentwatch.com/blog/enbrel-patent-expirations-and-biosimilar-competition
[3] https://www.drugpatentwatch.com/search/etanercept-biosimilar
[4] https://www.drugpatentwatch.com/drugs/enbrel/dosing



Other Questions About Enbrel :

Is enbrel for psoriasis? Is enbrel or humira better for rheumatoid arthritis? Does enbrel work? Can enbrel cause new onset heart failure? What are the side effects of enbrel? Is enbrel for arthritis? How does enbrel compare to humira for rheumatoid arthritis?